UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

þ		QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the quarterly period ended May 5, 2007.

OR

o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the transition period from __________________________ to _______________________.

Commission file number 001-14565

FRED’S, INC.

(Exact name of registrant as specified in its charter)

Tennessee		62-0634010
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)
4300 New Getwell Rd., Memphis, Tennessee		38118
(Address of principal executive offices)		(zip code)

(901) 365-8880
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes o      No o.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.

Large accelerated filer o      Accelerated filer x      Non-accelerated filer o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act. Yes o      No x.

The registrant had 40,082,522 shares of Class A voting, no par value common stock outstanding as of June 8, 2007.

FRED’S, INC.

INDEX

		Page No.
Part I — Financial Information
Item 1 - Financial Statements (unaudited):
Condensed Consolidated Balance Sheets as of May 5, 2007 and February 3, 2007			3
Condensed Consolidated Statements of Income for the Thirteen Weeks Ended May 5, 2007 and April 29, 2006			4
Condensed Consolidated Statements of Cash Flows for the Thirteen Weeks Ended May 5, 2007 and April 29, 2006			5
Notes to Condensed Consolidated Financial Statements			6-12
Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations			13-16
Item 3 — Quantitative and Qualitative Disclosure about Market Risk			16
Item 4 — Controls and Procedures			17
Part II — Other Information			17
Item 6 — Exhibits
Signatures			18
Ex-31.1 Section 302 Certification of the CEO
Ex-31.2 Section 302 Certification of the CFO
Ex-32 Section 906 Certification of the CEO & CFO

Part 1 — FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS

FRED’S, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except for number of shares)

		May 5,				February 3,
		2007				2007
		(unaudited)
ASSETS:
Current assets:
Cash and cash equivalents		$	2,727			$	2,475
Inventories			348,793				304,969
Receivables, less allowance for doubtful accounts of $752 and $719, respectively			29,257				29,097
Other non-trade receivables			17,515				18,953
Prepaid expenses and other current assets			10,359				12,224
Total current assets			408,651				367,718
Property and equipment, at depreciated cost			136,892				138,031
Equipment under capital leases, less accumulated amortization of $4,665 and $4,578, respectively			302				390
Other noncurrent assets, net			9,343				9,570
Total assets		$	555,188			$	515,709
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable		$	85,860			$	64,349
Current portion of indebtedness			18				385
Current portion of capital lease obligations			318				352
Accrued expenses and other			39,434				42,159
Deferred income taxes			15,369				16,396
Income taxes payable			1,764				4,188
Total current liabilities			142,763				127,829
Long-term portion of indebtedness			17,479				2,216
Deferred income taxes			11,163				12,425
Capital lease obligations, long term portion			40				115
Other noncurrent liabilities			11,253				3,856
Total liabilities			182,698				146,441
Commitments and Contingencies
Shareholders’ equity:
Preferred stock, nonvoting, no par value, 10,000,000 shares authorized, none outstanding			—				—
Preferred stock, Series A junior participating nonvoting, no par value, 224,594 shares authorized, none outstanding			—				—
Common stock, Class A voting, no par value, 60,000,000 shares authorized, 40,082,774 and 40,068,953 shares issued and outstanding, respectively			136,617				135,803
Common stock, Class B nonvoting, no par value, 11,500,000 shares authorized, none outstanding			—				—
Retained earnings			234,806				232,382
Accumulated other comprehensive income			1,067				1,083
Total shareholders’ equity			372,490				369,268
Total liabilities and shareholders’ equity		$	555,188			$	515,709

See accompanying notes to condensed consolidated financial statements.

FRED’S, INC.

(unaudited)

(in thousands, except per share amounts)

		Thirteen Weeks Ended
		May 5,				April 29,
		2007				2006
Net sales		$	442,262			$	416,878
Cost of goods sold			315,261				297,034
Gross profit			127,001				119,844
Depreciation and amortization			7,227				7,109
Selling, general and administrative expenses			108,617				101,687
Operating income			11,157				11,048
Interest income			(133	)			(47	)
Interest expense			37				42
Income before income taxes			11,253				11,053
Income taxes			3,815				3,755
Net income		$	7,438			$	7,298
Net income per share:
Basic		$	.19			$	.18
Diluted		$	.19			$	.18
Weighed average shares outstanding:
Basic			39,842				39,711
Effect of dilutive stock options			118				129
Diluted			39,960				39,840
Dividends declared per common share		$	.02			$	.02
Comprehensive income:
Net income		$	7,438			$	7,298
Other comprehensive income (expense), net of tax:
Postretirement plan adjustment			(16	)			—
Comprehensive income		$	7,422			$	7,298

See accompanying notes to condensed consolidated financial statements.

FRED’S, INC.

(unaudited)
(in thousands)

		Thirteen Weeks Ended
		May 5,				April 29,
		2007				2006
Cash flows from operating activities:
Net income		$	7,438			$	7,298
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization			7,227				7,109
Net gain on asset disposition			307				(18	)
Stock-based compensation			676				347
Provision for uncollectible receivables			33				84
LIFO reserve increase			932				712
Deferred income tax expense			236				1,037
Provision for post retirement medical			(16	)			—
Excess tax benefits from stock-based compensation			4				(44	)
(Increase) decrease in assets:
Trade receivables			1,245				(7,144	)
Inventories			(44,756	)			(13,924	)
Other assets			1,865				1,705
Increase (decrease) in liabilities:
Accounts payable and accrued expense			18,786				11,415
Income taxes payable			(2,428	)			(3,493	)
Other noncurrent liabilities			659				(212	)
Net cash (used in) provided by operating activities			(7,792	)			4,872
Cash flows from investing activities:
Capital expenditures			(6,005	)			(5,087	)
Proceeds from asset dispositions			270				98
Asset acquisitions, net (primarily intangibles)			(345	)			(1,047	)
Net cash used in investing activities			(6,080	)			(6,036	)
Cash flows from financing activities:
Payments of indebtedness and capital lease obligations			(480	)			(514	)
Proceeds from revolving line of credit, net of payments			15,267				1,418
Excess tax benefits from stock-based compensation			(4	)			44
Proceeds from exercise of stock options and issuances under employee stock purchase plan			142				618
Cash dividends paid			(801	)			(798	)
Net cash provided by financing activities			14,124				768
Increase (decrease) in cash and cash equivalents			252				(396	)
Beginning of period cash and cash equivalents			2,475				3,145
End of period cash and cash equivalents		$	2,727			$	2,749
Supplemental disclosures of cash flow information:
Interest paid		$	25			$	64
Income taxes paid		$	6,000			$	6,200
Non-cash investing and financial activities:
Assets acquired with term loan		$	—			$	100

See accompanying notes to condensed consolidated financial statements.

FRED’S, INC.

NOTE 1: BASIS OF PRESENTATION

Fred’s, Inc. and subsidiaries (“We”, “Our”, “Us” or “Company”) operates as of May 5, 2007, 701 discount general merchandise stores, including 24 franchised Fred’s stores, in 15 states in the southeastern United States. 291 of the stores have full service pharmacies.

The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and are presented in accordance with the requirements of Form 10-Q and therefore do not include all information and notes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with GAAP. The statements do reflect all adjustments (consisting of only normal recurring accruals), which are, in the opinion of management, necessary for a fair presentation of financial position in conformity with GAAP. The statements should be read in conjunction with the Notes to the Consolidated Financial Statements for the fiscal year ended February 3, 2007 incorporated into Our Annual Report on Form 10-K.

The results of operations for the thirteen-week period ended May 5, 2007 are not necessarily indicative of the results to be expected for the full fiscal year.

NOTE 2: RECENT ACCOUNTING PRONOUNCEMENTS

In September 2006, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 157, “Fair Value Measurements”, (“SFAS No. 157”) which is effective for fiscal years beginning after November 15, 2007 and for interim periods within those years. This statement defines fair value, establishes a framework for measuring fair value and expands the related disclosure requirements. This statement is effective for the 2008 fiscal year, although early adoption is permitted. The Company is in the process of determining the effect, if any, that the adoption of SFAS 157 will have on its results of operations or financial position.

In February 2007, the Financial Accounting Standards Board issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities—Including an Amendment of FASB Statement No. 115, (“SFAS No. 159”). SFAS No. 159 allows companies the choice to measure many financial instruments and certain other items at fair value. This gives a company the opportunity to mitigate volatility in reported earnings caused by measuring related assets and liabilities differently without having to apply complex hedge accounting provisions. SFAS No. 159 is effective for fiscal years beginning after November 15, 2007. We are currently reviewing the impact of SFAS No. 159 on our Consolidated Financial Statements and expect to complete this evaluation in 2007.

In March 2007, the Emerging Issues Task Force (“EITF”) reached a consensus on issue number 06-10, “Accounting for Deferred Compensation and Postretirement Benefit Aspects of Collateral Assignment Split-Dollar Life Insurance Arrangements,” (“EITF 06-10”). EITF 06-10 provides guidance to help companies determine whether a liability for the postretirement benefit associated with a collateral assignment split-dollar life insurance arrangement should be recorded in accordance with either SFAS No. 106, “Employers’ Accounting for Postretirement Benefits Other Than Pensions” (if, in substance, a postretirement benefit plan exists), or Accounting Principles Board Opinion No. 12 (if the arrangement is, in substance, an individual deferred compensation contract). EITF 06-10 also provides guidance on how a company should recognize and measure the asset in a collateral assignment split-dollar life insurance contract. EITF 06-10 is effective for fiscal years beginning after December 15, 2007, although early adoption is permitted. The Company is in the process of determining the effect, if any, that the adoption of EITF 06-10 will have on its results of operations or financial position.

NOTE 3: INVENTORIES

Merchandise inventories are valued at the lower of cost or market using the retail first-in, first-out (FIFO) method for goods in our stores and the cost first-in, first-out (FIFO) method for goods in our distribution centers. The retail inventory method is a reverse mark-up, averaging method which has been widely used in the retail industry for many years. This method calculates a cost-to-retail ratio that is applied to the retail value of inventory to determine the cost value of inventory and the resulting cost of goods sold and gross margin. The assumption that the retail inventory method provides for valuation at lower of cost or market and the inherent uncertainties therein are discussed in the following paragraphs.

In order to assure valuation at the lower of cost or market, the retail value of our inventory is adjusted on a consistent basis to reflect current market conditions. These adjustments include increases to the retail value of inventory for initial markups to set the selling price of goods or additional markups to adjust pricing for inflation and decreases to the retail value of inventory for markdowns associated with promotional, seasonal or other declines in the market value. Because these adjustments are made on a consistent basis and are based on current prevailing market conditions, they approximate the carrying value of the inventory at net realizable value (market value). Therefore, the cost value of our inventory is stated at the lower of cost or market as is prescribed by U.S. GAAP.

Because the approximation of net realizable value (market value) under the retail inventory method is based on estimates such as markups, markdowns and inventory losses (shrink) there exists an inherent uncertainty in the final determination of inventory cost and gross margin. In order to mitigate that uncertainty, the Company has a formal review by product class which considers such variables as current market trends, seasonality, weather patterns and age of merchandise to ensure that markdowns are taken currently, or a markdown reserve is established to cover future anticipated markdowns. This review also considers current pricing trends and inflation to ensure that markups are taken if necessary. The estimation of inventory losses is a significant element in approximating the carrying value of inventory at net realizable value, and as such the following paragraph describes our estimation method as well as the steps we take to mitigate the risk of this estimate in the determination of the cost value of inventory.

The Company calculates inventory losses (shrink) based on actual inventory losses occurring as a result of physical inventory counts during each fiscal period and estimated inventory losses occurring between yearly physical inventory counts. The estimate for shrink occurring in the interim period between physical counts is calculated on a store- specific basis and is based on history, as well as performance on the most recent physical count. It is calculated by multiplying each store’s shrink rate, which is based on the previously mentioned factors, by the interim period’s sales for each store. Additionally, the overall estimate for shrink is adjusted at the corporate level to a three-year historical average to ensure that the overall shrink estimate is the most accurate approximation of shrink based on the Company’s overall history of shrink. The three-year historical estimate is calculated by dividing the “book to physical” inventory adjustments for the trailing 36 months by the related sales for the same period. In order to reduce the uncertainty inherent in the shrink calculation, the Company first performs the calculation at the lowest practical level (by store) using the most current performance indicators. This ensures a more reliable number, as opposed to using a higher level aggregation or percentage method. The second portion of the calculation ensures that the extreme negative or positive performance of any particular store or group of stores does not skew the overall estimation of shrink. This portion of the calculation removes additional uncertainty by eliminating short-term peaks and valleys that could otherwise cause the underlying carrying cost of inventory to fluctuate unnecessarily. The Company has not experienced any significant change in shrink as a percentage of sales from year to year during the subject reporting periods.

Management believes that the Company’s Retail Inventory Method provides an inventory valuation which reasonably approximates cost and results in carrying

inventory at the lower of cost or market. For pharmacy inventories, which were approximately $35.0 million and $36.4 million at May 5, 2007 and February 3, 2007, respectively, cost was determined using the retail LIFO (last-in, first-out) method in which inventory cost is maintained using the Retail Inventory Method, then adjusted by application of the Producer Price Index published by the U.S. Department of Labor for the cumulative annual periods. The current cost of inventories exceeded the LIFO cost by approximately $14.7 million at May 5, 2007 and $13.8 million at February 3, 2007.

NOTE 4: STOCK-BASED COMPENSATION

The Company accounts for its stock-based compensation plans in accordance with Statement of Financial Accounting Standards No. 123(R), “Share-Based Payment”, (“SFAS No. 123(R)”). Under SFAS No. 123(R) stock-based compensation expense is based on awards ultimately expected to vest, and therefore has been reduced for estimated forfeitures. Forfeitures are estimated at the time of grant based on the Company’s historical forfeiture experience and will be revised in subsequent periods if actual forfeitures differ from those estimates.

SFAS 123(R) also requires the benefits of income tax deductions in excess of recognized compensation cost to be reported as a financing cash flow, rather than as an operating cash flow as required prior to SFAS 123(R).

A summary of the Company’s stock-based compensation (a component of selling and general and administrative expenses) and related income tax benefit is as follows (in thousands):

		Thirteen Weeks Ended
		May 5,				April 29,
		2007				2006
Stock option expense		$	484			$	152
Restricted stock expense			140				107
ESPP expense			52				89
Total stock-based compensation		$	676			$	348
Income tax benefit on stock-based compensation		$	114			$	38

The fair value of each option granted during the thirteen weeks ended May 5, 2007 and April 29, 2006, respectively, is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:

		Thirteen Weeks Ended
		May 5,				April 29,
		2007				2006
Stock Options
Expected volatility			41.0	%			41.5	%
Risk-free interest rate			4.4	%			4.9	%
Expected option life (in years)			5.84				5.85
Expected dividend yield			0.40	%			0.35	%
Weighted average fair value at grant date		$	6.49			$	6.16
Employee Stock Purchase Plan
Expected volatility			32.7	%			33.5	%
Risk-free interest rate			4.7	%			4.8	%
Expected option life (in years)			0.25				0.5
Expected dividend yield			0.15	%			0.13	%
Weighted average fair value at grant date		$	2.66			$	3.58

The following is a summary of the methodology applied to develop each assumption:

Expected Volatility — This is a measure of the amount by which a price has fluctuated or is expected to fluctuate. The Company uses actual historical changes in the market value of our stock to calculate expected price volatility because management believes that this is the best indicator of future volatility. The Company calculates weekly market value changes from the date of grant over a past period representative of the expected life of the options to determine volatility. An increase in the expected volatility will increase compensation expense.

Risk-free Interest Rate — This is the yield of a U.S. Treasury zero-coupon bond issue effective at the grant date with a remaining term equal to the expected life of the option. An increase in the risk-free interest rate will increase compensation expense.

Expected Lives — This is the period of time over which the options granted are expected to remain outstanding and is based on historical experience. Options granted have a maximum term of seven and one-half years. An increase in the expected life will increase compensation expense.

Dividend Yield — This is based on the historical yield for a period equivalent to the expected life of the option. An increase in the dividend yield will decrease compensation expense.

Forfeiture Rate — This is the estimated percentage of options granted that are expected to be forfeited or cancelled before becoming fully vested. This estimate is based on historical experience. An increase in the forfeiture rate will decrease compensation expense.

NOTE 5: Stock Plans

The 2004 Employee Stock Purchase Plan (the “2004 Plan”), which was approved by Fred’s stockholders, permits eligible employees to purchase shares of our common stock through payroll deductions at the lower of 85% of the fair market value of the stock at the time of grant or 85% of the fair market value at the time of exercise. There were 15,653 shares issued during the thirteen weeks ended May 5,

2007. There are 1,410,928 shares approved to be issued under the 2004 Plan and as of May 5, 2007, there were 1,279,588 shares available.

Stock Options

The following table summarizes stock option activity during the thirteen weeks ended May 5, 2007:

										Weighted
						Weighted				Average				Aggregate
						Average				Remaining				Intrinsic
						Exercise				Contractual				Value
		Options				Price				Life (Years)				(Thousands)
Outstanding at February 3, 2007			1,103,064			$	16.74				4.2			$	298
Granted			17,500			$	14.73
Forfeited/Cancelled			(25,500	)		$	19.48
Exercised			—
Outstanding at May 5, 2007			1,095,064			$	16.64				4.0			$	140
Exercisable at May 5, 2007			400,433			$	17.40				3.2			$	28

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between Fred’s closing stock price of $13.71 on the last trading day of the period ended May 5, 2007 and the exercise price of the option multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on that date. As of May 5, 2007, total unrecognized stock-based compensation expense net of estimated forfeitures related to non-vested stock options was approximately $1.69 million, which is expected to be recognized over a weighted average period of approximately 3.1 years. The total fair value of options vested during the thirteen weeks ended May 5, 2007 was $.56 million.

Restricted Stock

The following table summarizes restricted stock activity during the thirteen weeks ended May 5, 2007:

						Weighted
						Average
		Number				Grant Date
		of Shares				Fair Value
Non-vested Restricted Stock at February 3, 2007			229,851			$	15.03
Granted			534			$	14.98
Forfeited/Cancelled			(389	)		$	14.46
Vested			(4,142	)		$	17.52
Non-vested Restricted Stock at May 5, 2007			225,854			$	15.07

The aggregate pre-tax intrinsic value of restricted stock outstanding as of May 5, 2007 is $3.1 million with a weighted average remaining contractual life of 7.2 years. The unrecognized compensation expense net of estimated forfeitures, related to the outstanding stock is approximately $2.5 million, which is expected to be recognized over a weighted average period of approximately 6.7 years. The total fair value of restricted stock awards that vested during the thirteen weeks ended May 5, 2007 was $.07 million.

NOTE 6: Property and Equipment

Property and Equipment are carried at cost. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets. Improvements to leased premises are amortized using the straight-line method over the shorter of the initial term of the lease or the useful life of the improvement. Leasehold improvements added late in the lease term are amortized over the shorter of the remaining term of the lease (including the upcoming renewal option, if the renewal is reasonably assured) or the useful life of the improvement. Assets under capital leases are amortized in accordance with the Company’s normal depreciation policy for owned assets or over the lease term (regardless of renewal options), if shorter, and the charge to earnings is included in depreciation expense in the consolidated financial statements. Gains or losses on the sale of assets are recorded at disposal as a component of operating income. The following illustrates the breakdown of the major categories within Property and Equipment:

		May 5,				February 3,
		2007				2007
		(unaudited)
Building and building improvements		$	76,264			$	76,623
Furniture, fixtures and equipment			218,929				216,448
Leasehold improvements			46,819				45,097
Automobiles and vehicles			6,514				6,429
Airplane			4,697				4,697
			353,223				349,294
Less: Accumulated Depreciation and Amortization			(221,068	)			(215,879	)
			132,155				133,415
Construction in Progress			474				353
Land			4,263				4,263
Total Property and Equipment, at depreciated cost		$	136,892			$	138,031

NOTE 7: Income taxes

In June 2006, the Financial Accounting Standards Board issued FASB Interpretation No. 48 (“FIN 48”), Accounting for Uncertainty in Income Taxes — an Interpretation of FASB Statement No.109. We adopted FIN 48 as of February 4, 2007, the first day of fiscal 2007. This interpretation clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements in accordance with SFAS No. 109 and prescribes a minimum recognition threshold of more-likely-than-not to be sustained upon examination that a tax position must meet before being recognized in the financial statements. Under FIN 48, the impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Additionally, FIN 48 provides guidance on de-recognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition.

As a result of the adoption of FIN 48, we recognized a cumulative effect adjustment of $4.2 million decrease to beginning retained earnings and a reclassification of certain amounts between deferred income taxes ($2.3 million decrease) and other non-current liabilities ($6.5 million increase, including $1.0 million of interest and penalties) to conform to the balance sheet presentation requirements of FIN 48. During the first quarter of 2007, our FIN 48 reserve increased by $0.2 million, including $0.1 million of accrued interest. The Company includes potential interest and penalties recognized in accordance with FIN 48 in the financial statements as a component of income tax expense.

The Company had approximately $8.0 million of unrecognized tax benefits as of February 3, 2007. If recognized, approximately $5.9 million of the unrecognized tax benefits would affect the Company’s effective income tax rate.

We are subject to U.S. federal income tax as well as income tax of multiple state jurisdictions. The Company is open to federal and state tax audits until the applicable statute of limitations expire. The tax years 2000 through 2006 remain open to examination by the major taxing jurisdictions to which we are subject.

NOTE 8: Exit and disposal activities

During the year ended February 3, 2007, the Company recorded a below-cost inventory adjustment of approximately $1.2 million associated with the discontinuance of the boys and girls apparel departments. Also the Company recorded an additional below-cost inventory adjustment of $0.9 million for planned store closings. Both adjustments were recorded in cost of goods sold in the consolidated statements of income for the year ended February 3, 2007.

The Company also recorded approximately $0.9 million in selling, general and administrative expense in the consolidated statements of income for the year ended February 3, 2007 to reflect impairment charges for furniture and fixtures and leasehold improvements relating to the planned store closures mentioned above. Liability balances related to activities discussed above for stores closed during the quarter ended May 5, 2007 are as follows (in millions):

		Beginning				Utilized during				Ending
		Balance				1st Qtr				Balance
		February 3, 2007				2007				May 5, 2007
Inventory markdowns for discontinuance of boys & girls apparel		$	1.2			$	0.4			$	0.8
Inventory markdowns for planned store closings			0.9				0.4				0.5
Asset impairment for planned store closings			0.9				0.1				0.8
		$	3.0			$	0.9			$	2.1

During the current year, the Company has incurred or expects to incur the following pretax costs associated with said store closings (in millions):

		Estimated				Incurred in
		Total				2007				Remaining
Lease contract termination costs		$	1.7			$	0.5			$	1.2
Total		$	1.7			$	0.5			$	1.2

In addition to those stores that might be closed in the ordinary course of business, the Company is planning approximately 20 store and pharmacy closings during the course of 2007 (10 of which have been closed as of May 5, 2007).

NOTE 9: Accumulated other comprehensive income

		May 5,				April 29,				February 3,
(in thousands)		2007				2006				2007
Accumulated other comprehensive income		$	1,083			$	0			$	0
Adjustment to initially apply SFAS No. 158 (net of tax)											1,083
Amortization of postretirement benefit during quarter			(16	)			0
Ending balance		$	1,067			$	0			$	1,083

Effective February 3, 2007, the Company began recognizing the funded status of its postretirement benefits plan in accordance with SFAS No. 158. SFAS No. 158 requires the Company to display the net over-or-under funded position of a defined benefit postretirement plan as an asset or liability, with any unrecognized prior service costs, transition obligations or actuarial gains/losses reported as a component of accumulated other comprehensive income in stockholders’ equity. The activity within accumulated other comprehensive income in the first quarter of 2007 represents the amortization of prior service cost and net actuarial gains and losses through net periodic benefit cost.

Item 2:

Management’s Discussion and Analysis of Financial
Condition and Results of Operations

Executive Overview

During the first quarter of 2007, the Company continued its strategy of refreshing and revitalizing our stores and capitalizing on our 60 years of experience in the discount retail sector. We are continuing implementation of our Merchandise Refresher Program which had commenced in 20% of our stores by quarter-end. This program refreshes the look and feel of our stores with new paint and flooring, updated signage and the expansion and relocation of several departments. Additionally, our new branding and advertising campaign, which focuses on our 60 year history while emphasizing the new look and feel of Fred’s continued throughout the quarter. These strategies and our unique store layout allow us to offer our customers all the attractive elements of a discount dollar store, drug store and mass merchant under one roof. By offering elements of all three types of businesses, we are able to provide our customer with a “ten minute Superstore” experience in a smaller, easier and more convenient store layout.

As mentioned in our 10-K for the year ended February 3, 2007, we slowed our new store growth in the first quarter and will continue to do so through the remainder of the year. This slow down in growth, coupled with the closing of unproductive stores should have a positive impact on the Company’s operating margin over time. In the first quarter of 2007, the Company opened 11 new stores and closed 10 stores. The majority of our new store openings were in Alabama, Texas, and Mississippi. We did not enter into any new states during the quarter. Additionally, we opened six new pharmacies and closed four pharmacies during the quarter.

The Company continued during the first quarter to see paybacks on productivity improvements and key technology initiatives. Some of these include continuing enhancement of our point of sale and radio frequency (RF) store systems, refinement and upgrades to our merchandise planning and allocation systems and process and productivity standards improvements in our distribution centers. Pharmacy system improvements that enhance customer service also continue to be a key initiative.

During the remainder of 2007, we will continue with capital improvements in infrastructure, including new store expansion, distribution center upgrades and further development of our information technology capabilities.

As previously reported, the Company expects an increase of 12 % to 22% in earnings per diluted share for 2007. The Company bases this increase in estimated earnings for fiscal 2007 on the following assumptions:

•		Comparable store sales are anticipated to increase for the full year in the range of 3% to 5%. Total sales are expected to increase in the range of 6% to 9% for the year.
•		The Company expects to open 35 to 40 new stores, 15 to 25 new pharmacies, and expects to close 20 to 25 stores, netting growth in selling square footage in the range of 1% to 3% for the year.
•		Minimum wage legislation will benefit our customers, thereby increasing our sales, which offset expenses of increased labor costs.
•		The federally mandated Average Manufacturer’s Price (AMP) is expected to have a negative impact on gross profit from prescription drugs.
•		We anticipate additional costs of approximately $1.2 million associated with previously announced store closings.

Key factors that will be critical to the Company’s future success include managing the growth strategy for new stores and pharmacies, including the ability to open and operate effectively, maintaining high standards of customer service, maximizing efficiencies in the supply chain, controlling working capital needs through improved inventory turnover, controlling the effects of inflation, especially in regard to occupancy cost, increasing the operating margin through

improved gross profit margin and leveraging operating costs, and generating adequate cash flow to fund the Company’s expansion.

Other factors that will affect Company performance in 2007 include the continuing management of the impacts of the changing regulatory environment in which our pharmacy department operates, especially the anticipated implementation of the federally approved change in pricing of generic pharmaceuticals to Average Manufacturer’s Price (AMP), which could negatively affect gross margin. Also, the Company expects an initial negative impact in selling, general and administrative expenses from the raising of the Federal Minimum Wage; however, this increase should be a positive factor over time as it will directly impact the disposable income of our primary customer base.

Our business is subject to seasonal influences, but has tended to experience less seasonal fluctuation than many other retailers due to the mix of everyday basic merchandise and pharmacy business. Our fiscal fourth quarter is typically the most profitable quarter because it includes the Christmas selling season. The overall strength of the fourth quarter is partially mitigated, however, by the inclusion of the month of January, which is generally the least profitable month of the year.

The Company’s discussion and analysis of its financial condition and results of operations are based upon the Company’s condensed financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The critical accounting matters that are particularly important to the portrayal of the Company’s financial condition and results of operations and require some of management’s most difficult, subjective and complex judgments are described in detail in the Company’s Annual Report on Form 10-K for the fiscal year ended February 3, 2007. The preparation of condensed financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, including those related to inventories, income taxes, insurance reserves, contingencies and litigation. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The only material changes in critical accounting policies during the thirteen weeks ended May 5, 2007, was the adoption of FASB Interpretation No. 48 (“FIN 48”), Accounting for Uncertainty in Income Taxes — an Interpretation of FASB Statement No.109, which was discussed in detail in Note 7 of the financial statements included elsewhere in this document.

Thirteen Weeks Ended May 5, 2007 and April 29, 2006
Net sales increased to $442.3 million in 2007 from $416.9 million in 2006, an increase of $25.4 million or 6.1%. The increase was attributable to comparable store sales increases of 1.9% ($7.9 million) and sales by stores not yet included as comparable stores ($17.3 million). Sales to franchisees increased $.2 in 2007 compared to the same quarter last year. The sales mix for the period was 33.2% Pharmaceuticals, 23.1% Household Goods, 10.4% Apparel and Linens, 14.2% Food and Tobacco, 8.8% Paper and Cleaning Supplies, 8.2% Health and Beauty Aids, and 2.1% Franchise. This compares with 32.4% Pharmaceuticals, 23.4% Household Goods, 12.2% Apparel and Linens, 13.3% Food and Tobacco, 8.2% Health and Beauty Aids, 8.4% Paper and Cleaning Supplies, and 2.1% Franchise for the same period last year.

Gross profit for the first quarter was 28.7% of sales in 2007, the same as in 2006. During the quarter, the initial markup was slightly lower than a year ago due to an unfavorable shift in the product mix toward basic and consumable products which was mostly offset by lower markdowns and additional vendor rebates.

Selling, general and administrative expenses increased to $115.8 million in 2007

from $108.8 million in 2006. Selling, general and administrative expenses increased primarily from lease related costs of closed stores ($0.5 million) and additional stock option expenses ($0.3 million) over the first quarter of last year. Excluding these components, selling, general and administrative expenses as a percentage of sales were flat with the first quarter of last year. On the positive side, labor expenses leveraged by 14 basis points as a percent of sales despite the added work in the stores as we implement our Store Refresher Program. As a percentage of sales, expenses increased to 26.2% of sales compared to 26.0% of sales last year.

For the first quarter of 2007, the Company earned net interest income of $0.1 million.

For the first quarter of 2006, the effective income tax rate was 33.9%, as compared to 34.0% in the first quarter of last year. We continue to see positive impact from Katrina related jobs credits and anticipate the income tax rate for the remainder of the year to be in the 33% to 35% range.

LIQUIDITY AND CAPITAL RESOURCES

Due to the seasonality of our business and the continued increase in the number of stores and pharmacies, inventories are generally lower at year-end than at each quarter-end of the following year.

Cash used in operating activities totaled $7.8 million during the thirteen-week period ended May 5, 2007. Cash was primarily used to increase inventories by approximately $44.8 million in the first quarter of 2007. This increase was primarily attributable to 11 new stores and increases in our basic product inventories to improve in-stock positions, and additional inventories related to the new stationery program and check-out aisle resets. Accounts payable and accrued expenses increased by approximately $18.8 million in the first quarter of 2007 due to the increase in inventory.

Cash used in investing activities totaled $6.1 million, and consisted primarily of capital expenditures associated with the store and pharmacy expansion program ($3.5 million), expenditures related to the Store Refresher Program ($2.3 million) and technology and other corporate expenditures ($.2 million). During the first quarter of 2007, we opened 11 stores, closed 10 stores, opened 6 pharmacies, and closed 4 pharmacies. We expect to open 5 to 7 stores in the second quarter and approximately 35 to 40 stores for the year. In 2007, the Company is planning capital expenditures totaling approximately $27.5 million. Expenditures are planned totaling approximately $20.3 million for upgrades, remodels, or new stores and pharmacies; $5.2 million for technology upgrades, $2.0 million for distribution center equipment and capital replacements. In addition, the Company also plans expenditures of $2.6 million for the acquisition of customer lists and other pharmacy related items. Depreciation expense for 2007 will be approximately $29 million.

Cash provided by financing activities totaled $14.1 million and included $15.3 million of borrowings under the Company’s revolving credit agreement for inventory needs. There were $17.4 million in borrowings outstanding at May 5, 2007 and $2.2 million in borrowings outstanding at February 3, 2007.

We believe that sufficient capital resources are available in both the short-term and long-term through currently available cash and cash generated from future operations and, if necessary, the ability to obtain additional financing.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

Other than statements based on historical facts, many of the matters discussed in this Form 10-Q relate to events which we expect or anticipate may occur in the future. Such statements are defined as “forward-looking statements” under the Private Securities Litigation Reform Act of 1995 (the “Reform Act”), 15 U.S.C.A. Sections 77z-2 and 78u-5 (Supp. 1996). The Reform Act created a safe harbor to protect companies from securities law liability in connection with forward-looking statements. We intend to qualify both our written and oral forward-looking statements for protection under the Reform Act and any other similar safe harbor provisions.

The words “believe”, “anticipate”, “project”, “plan”, “expect”, “estimate”, “objective”, “forecast”, “goal”, “intend”, “will likely result”, or “will continue” and similar expressions generally identify forward-looking statements. All forward-looking statements are inherently uncertain, and concern matters that involve risks and other factors that may cause the actual performance of the Company to differ materially from the performance expressed or implied by these statements. Therefore, forward-looking statements should be evaluated in the context of these uncertainties and risks, including but not limited to:

	o		Economic and weather conditions which affect buying patterns of our customers and supply chain efficiency.
	o		Changes in consumer spending and our ability to anticipate buying patterns and implement appropriate inventory strategies.
	o		Continued availability of capital and financing.
	o		Competitive factors.
	o		Changes in reimbursement practices for pharmaceuticals.
	o		Governmental regulation.
	o		Increases in fuel and utility rates.
	o		Other factors affecting business beyond our control, including (but not limited to) those discussed under Part 1, ITEM 1A “Risk Factors” of the Company’s Annual Report on Form 10-K for the fiscal year ended February 3, 2007.

Consequently, all forward-looking statements are qualified by this cautionary statement. We undertake no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

Item 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK

We have no holdings of derivative financial or commodity instruments as of May 5, 2007. We are exposed to financial market risks, including changes in interest rates. All borrowings under our Revolving Credit Agreement bear interest at 1.5% below prime rate or a LIBOR-based rate. An increase in interest rates of 100 basis points would not significantly affect our income. All of our business is transacted in U.S. dollars and, accordingly, foreign exchange rate fluctuations have not had a significant impact on us, and they are not expected to in the foreseeable future.

Item 4.

CONTROLS AND PROCEDURES

     (a) Disclosure Controls and Procedures. As of the end of the period covered by this report, the Company carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer, concluded that, as of the date of their evaluation, the Company’s disclosure controls and procedures are effective in timely alerting them to material information required to be included in the Company’s periodic SEC reports, subject to the effectiveness of the Company’s internal control over financial reporting. Consistent with the suggestion of the Securities and Exchange Commission, the Company has formed a Disclosure Committee consisting of key Company personnel designed to review the accuracy and completeness of all disclosures made by the Company.

     (b) Changes in Internal Control over Financial Reporting. There have been no changes in the Company’s internal control over financial reporting that occurred during the Company’s first fiscal quarter that have materially affected or are reasonably likely to materially affect the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 6. Exhibits

Exhibits:
	31.1			Certification of Chief Executive Officer.
	31.2			Certification of Chief Financial Officer.
	32.			Certification of Chief Executive Officer and Chief Financial Officer pursuant to rule 13a—14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.